12th may 2023 - Dextrain announces that its Manipulandum has obtained certification as a Medical Device (MD). This rehabilitation system has been adopted by 10 healthcare institutions and research organizations, allowing more than a hundred patients to benefit from its benefits.
19th december 2022 - Dextrain starts its Haptics project, winner of a funding from the French National Research Agency (ANR). This ambitious project aims to combine haptics with Manipulandum to evaluate and train the tactile sensitivity of fingers.
20th june 2022 - Dextrain creates a partnership with the Ramsay Santé Provence Bourbonne clinic to deploy the S’TIM software, an innovation in neurological rehabilitation
8th december 2021 - Dextrain integrates iPEPS - The Healthtech Hub, the Brain Institute's startup incubator
29th september 2021 - Dextrain will participate in Rééduca 2021, the meeting place for rehabilitation and physiotherapy, from September 30 to October 2, 2021, at the Porte de Versailles exhibition center (Pav4, stand G61). On this occasion, the company will present to healthcare professionals its innovative solutions for the rehabilitation of manual dexterity resulting: the Dextrain Manipulandum and the Dextrain Home Care tablet.
17th june 2021 - Dextrain reports the creation of its Scientific Committee
3rd june 2021 - Dextrain, transforming neuro-rehabilitation of post-stroke patients
After less than a year of existence, Dextrain has already been recognized for its innovative character by rehabilitation professionals, winning successively the Rééduca Innov' Award at the Rééduca in Paris and the Innovation Handicap Award awarded by Thuasne at the 36th SOFMER Congress in Lille.